Blossomhill Therapeutics
Clinical trials sponsored by Blossomhill Therapeutics, explained in plain language.
-
New pill for tough leukemia cases enters human testing
Disease control Recruiting nowThis early-stage study tests a new daily pill, BH-30236, in adults whose acute myeloid leukemia or high-risk myelodysplastic syndrome has returned or stopped responding to other treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink ca…
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:13 UTC
-
New hope for lung cancer: targeted drug BH-30643 enters human trials
Disease control Recruiting nowThis study tests a new drug, BH-30643, in adults with advanced non-small cell lung cancer that has certain gene changes (EGFR or HER2 mutations). The goal is to find a safe dose and see if the drug shrinks tumors. About 266 people will take part across multiple centers.
Phase: PHASE1, PHASE2 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:53 UTC